Trial intelligence / Profile preview

Safety and Tolerability of Buprenorphine/Naloxone Film in Opioid Dependence

NCT00640835Phase 2Completed

Sponsor
Indivior
Start
Feb 2008
Primary completion
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of buprenorphine + naloxone in opioid use disorder (OUD), sponsored by Indivior. Started Feb 2008; status: completed.

02

Drugs

buprenorphine + naloxone
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on NCT00640835.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00640835.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call